Connect® Myeloid Disease Registry
- Conditions
- Primary MyelofibrosisMyelodysplastic SyndromesLeukemia, Myeloid, Acute
- Interventions
- Registration Number
- NCT01688011
- Lead Sponsor
- Celgene
- Brief Summary
The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.
- Detailed Description
This Disease Registry will collect data on patient characteristics, treatment patterns and clinical outcomes. The objective is to describe how patients with myeloid diseases are treated; and to build a knowledge base regarding the effectiveness and safety of first line and subsequent treatment regimens in both community and academic settings. Enrolled patients will receive treatment and evaluations for their disease according to the standard of care and routine clinical practice at each study site. All treatments that patients receive for their disease will be recorded, including initial treatment and any subsequent therapy. Data on treatment outcomes, including response rates as measured by the treating physician, evidence of progression, survival, and patient-reported outcomes will be collected quarterly on the electronic CRF.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2300
- Patients must be able to provide written informed consent form (ICF)
- Must be willing and able to complete baseline and follow-up HRQoL instruments, for which patients must be proficient in either English or Spanish
- AML patients must be at least 55 years of age at the time of informed consent.
- MF, ICUS, and MDS patients must be at least 18 years of age at the time of informed consent.
Newly diagnosed Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) patients:
- Newly diagnosed primary or secondary disease. To be considered "newly diagnosed", a patient's confirmed diagnosis must be made no more than 60 days prior to the date of consent signature. (An additional 5-day window [i.e., up to 65 days prior to the date of ICF signature] may be allowed in special circumstance upon sponsor approval)
- Cohort assignment confirmed by central eligibility review. Cohort assignment must also be confirmed by the site.
Myelofibrosis (MF) patients:
- Patients who initiated their first active systemic treatment for MF and/or MF-related cytopenias within 90 days prior to the date of consent signature. This cohort allows the enrollment of subjects with a diagnosis of Myelodysplastic/Myeloproliferative overlap syndromes (MDS/MPN overlap syndrome).
- Cohort assignment is confirmed by the site. Central eligibility review is not required.
Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS) patients:
- Patients who have initiated first active treatment regimen containing at least one non-ESA therapy, within 90 days prior to ICF
- Cohort assignment is confirmed by site. Central eligibility review is not required.
Luspatercept treated patients:
- Patient must have been at least 18 years of age at the start of luspatercept.
- Among LR-MDS patients, patient must have initiated luspatercept on or after September 1, 2023, must be ESA-naïve and luspatercept must be the first active treatment (as monotherapy or part of a treatment regimen) for their disease.
- Among all other myeloid malignancies, there is no date restriction for initiation of luspatercept .Patient may have received prior treatment for their disease.
- Patient must have at least 3 months of follow-up from start of luspatercept treatment at the participating site.
- Suspected or proven acute promyelocytic leukemia (APL) (FAB M3 or WHO 2008) based on morphology, immunophenotype, molecular assay or karyotype
- Currently enrolled in any interventional clinical trial where the patient is being treated with an investigational product that cannot be identified.
- Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic Syndromes (MDS) patients who received or are receiving active (disease modifying) therapy for the treatment of MDS prior to the date of informed consent.
- Acute Myeloid Leukemia (AML) patients who initiated active (disease modifying treatment for AML more than 2 weeks prior to the date of consent.
- Myelofibrosis (MF) and Myelodysplastic/Myeloproliferative (MDS/MPN) overlap syndrome patients with suspected juvenile myelomonocytic leukemia (JMML).
Luspatercept treated patients:
- Patient must not be currently or previously enrolled in the Connect Myeloid Registry.
- Patient must not have received luspatercept as part of a clinical trial.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Luspatercept treated cohort (LTC) Luspatercept Participants that have initiated luspatercept treatment for a myeloid malignancy.
- Primary Outcome Measures
Name Time Method Patient Demographics- MDS/AML/ICUS Cohorts Up to 8 years Describe demographics, baseline characteristics and clinical outcomes of the patients with LR or HR MDS, ICUS, and AML.
Safety and Effectiveness- MF Cohort Up to 5 years Describe the survival status, clinical response to treatment, select laboratory results, occurrence of secondary primary malignancies, deaths, select adverse events.
Treatment effectiveness - LTC Minimum of 3-months post index date Describe clinical response to treatment, transfusion information, ECOG performance status and deaths.
Diagnostic and Treatment Patterns- MDS/AML/ICUS Cohorts Up to 8 years Describe current and evolving patterns for diagnosis, treatment sequencing, routine clinical practice patterns and clinical outcome measures in patients with LR or HR MDS, ICUS, and AML
Safety and Effectiveness- MDS/AML/ICUS Cohorts Up to 8 years Describe the survival status, clinical response to treatment, select laboratory results, occurrence of secondary primary malignancies, deaths, select adverse events.
Diagnostic and Treatment Patterns- MF Cohort Up to 5 years Describe current and evolving patterns for diagnosis, treatment sequencing, routine clinical practice patterns and clinical outcome measures in patients enrolled in the MF Cohort
Treatment patterns and clinical outcomes - LTC Cohort Minimum of 3-months post index date Describe the myeloid malignancy treatment patterns and clinical outcomes before and after initiating luspatercept treatment
Treatment duration - LTC Cohort Minimum of 3-months post index date Luspatercept treatment duration
Patient Demographics- MF Cohort Up to 5 years Describe demographics, baseline characteristics, patient recorded outcomes, and clinical outcomes of patients enrolled to the MF cohort
Transfusion information - LTC Minimum of 3-months post index date Describe changes in hemoglobin and transfusion independence status.
- Secondary Outcome Measures
Name Time Method Patient demographics and clinical characteristics - LTC Baseline Describe demographics, baseline characteristics and clinical outcomes of the patients treated with luspatercept
Reason for treatment discontinuation - LTC Minimum of 3-months post index date Describe reasons for luspatercept treatment discontinuation
Patient Reported Outcome Up to 8 years Summarize patient reported outcomes (including e.g., Health-Related Quality of Life (HRQOL)) and economic outcomes, and their association with patient characteristics, treatment regimens, and clinical outcomes
Correlative Studies Up to 8 years Perform molecular and cellular correlative studies on blood/bone marrow and oral epithelial cell samples.
Trial Locations
- Locations (239)
Local Institution - 1088
🇺🇸Cleveland, Ohio, United States
Southern Nevada Cancer Research Foundation
🇺🇸Las Vegas, Nevada, United States
TriHealth, Good Samaritan Hospital
🇺🇸Cincinnati, Ohio, United States
Alta Bates Summit Comprehensive Cancer
🇺🇸Berkeley, California, United States
Local Institution - 1027
🇺🇸Santa Rosa, California, United States
Comprehensive Blood & Cancer Center
🇺🇸Bakersfield, California, United States
Genesis Cancer Center
🇺🇸Hot Springs, Arkansas, United States
Highlands Oncology Group
🇺🇸Fayetteville, Arkansas, United States
The University of Arizona Cancer Center
🇺🇸Tucson, Arizona, United States
Local Institution - 1161
🇺🇸Jonesboro, Arkansas, United States
Marin Cancer Care
🇺🇸Greenbrae, California, United States
Local Institution - 1273
🇺🇸Tucson, Arizona, United States
CARTI
🇺🇸Little Rock, Arkansas, United States
ONCOLOGY SPECIALTIES, PC - Clearview Cancer Institute
🇺🇸Huntsville, Alabama, United States
VA Central California Health Care System
🇺🇸Fresno, California, United States
Clopton Clinic of Jonesboro, Inc.
🇺🇸Jonesboro, Arkansas, United States
DCH Health System (Lewis and Faye Manderson Cancer Center)
🇺🇸Tuscaloosa, Alabama, United States
Sutter East Bay Hospitals (dba Jordan Research and Education Institute - REDI)
🇺🇸Berkeley, California, United States
Regional Cancer Care Associates
🇺🇸Manchester, Connecticut, United States
Mercy Hospital Fort Smith
🇺🇸Fort Smith, Arkansas, United States
Ashwin Kashyap MD, INC.
🇺🇸Thousand Oaks, California, United States
Pacific Cancer Care
🇺🇸Monterey, California, United States
NEABC- Fowler Family Center for Cancer Care
🇺🇸Jonesboro, Arkansas, United States
Delaware Clinical and Laboratory Physicians
🇺🇸Christiana, Delaware, United States
John Muir Clinical Research Center
🇺🇸Concord, California, United States
Robert A. Moss, M.D.,F AC.P, Inc
🇺🇸Fountain Valley, California, United States
UCSD Moores Cancer Center
🇺🇸La Jolla, California, United States
Halifax Health Center for Oncology
🇺🇸Daytona Beach, Florida, United States
St. Joseph's Regional Cancer Center
🇺🇸Stockton, California, United States
MedStar Health Research Institute (Washington)
🇺🇸Washington, District of Columbia, United States
Piedmont Cancer Institute, P.C. (was Peachtree Hematology-Oncology Consultants)
🇺🇸Atlanta, Georgia, United States
Local Institution - 1016
🇺🇸San Diego, California, United States
HealthCare Alliance (UHA)
🇺🇸Pleasanton, California, United States
Watson Clinic Center for Cancer Care and Research
🇺🇸Lakeland, Florida, United States
Carle Cancer Center
🇺🇸Urbana, Illinois, United States
Phoebe Putney Memorial Hospital
🇺🇸Albany, Georgia, United States
21st Century Oncology
🇺🇸Orange Park, Florida, United States
Southeast FL Hematology Oncology Grp
🇺🇸Fort Lauderdale, Florida, United States
Ingalls Memorial Hospital
🇺🇸Harvey, Illinois, United States
Cancer Specialists of North Florida
🇺🇸Jacksonville, Florida, United States
Georgia Regents University Cancer Center
🇺🇸Augusta, Georgia, United States
Simmons Cancer Institute at Southern Illinois University
🇺🇸Springfield, Illinois, United States
St Joseph Heritage Healthcare
🇺🇸Santa Rosa, California, United States
McFarland Clinic, P.C
🇺🇸Ames, Iowa, United States
Joliet Oncology Hematology Associates Ltd
🇺🇸Joliet, Illinois, United States
Floyd Memorial Cancer Center of Indiana
🇺🇸New Albany, Indiana, United States
Bond Clinic
🇺🇸Winter Haven, Florida, United States
Covenant Clinic
🇺🇸Waterloo, Iowa, United States
Hektoen Inst for Medical Resrch on behalf of itself and John H Stroger Hosp
🇺🇸Chicago, Illinois, United States
Broward Oncology Associates
🇺🇸Fort Lauderdale, Florida, United States
Tallahassee Memorial Cancer Center
🇺🇸Tallahassee, Florida, United States
Edward H. KaPlan MD & Associates
🇺🇸Skokie, Illinois, United States
Orchard Healthcare Research Inc.
🇺🇸Skokie, Illinois, United States
Bennett Cancer Center Stamford Hospital
🇺🇸Stamford, Connecticut, United States
RUSH University Cancer Center
🇺🇸Chicago, Illinois, United States
Sacred Heart Medical Oncology Group
🇺🇸Pensacola, Florida, United States
St. Vincent Anderson Regional Hospital Research
🇺🇸Anderson, Indiana, United States
Good Samaritan Hospital - Wabash Valley Clinical Research Center
🇺🇸Vincennes, Indiana, United States
University of Florida College of Medicine
🇺🇸Jacksonville, Florida, United States
NorthShore University Health System
🇺🇸Evanston, Illinois, United States
Our Lady of the Lake Physician Group-Medical Oncology
🇺🇸Baton Rouge, Louisiana, United States
Holy Cross Hospital
🇺🇸Fort Lauderdale, Florida, United States
Broward Health Medical Center
🇺🇸Fort Lauderdale, Florida, United States
Saint Alphonsus Regional Medical Center
🇺🇸Boise, Idaho, United States
Northwest Georgia Oncology Centers, P.C.
🇺🇸Marietta, Georgia, United States
Columbus Regional Research Institute
🇺🇸Columbus, Georgia, United States
Local Institution - 1145
🇺🇸Joliet, Illinois, United States
Cancer Care Centers of Brevard
🇺🇸Rockledge, Florida, United States
Space Coast Medical Associates
🇺🇸Titusville, Florida, United States
Quincy Medical Group
🇺🇸Quincy, Illinois, United States
Cancer and Blood Disease Center
🇺🇸Lecanto, Florida, United States
Emory University
🇺🇸Atlanta, Georgia, United States
Illinois Cancer Care
🇺🇸Peoria, Illinois, United States
Ocala Oncology
🇺🇸Ocala, Florida, United States
Indian River Memorial Hospital Scully Welsh Cancer Center
🇺🇸Vero Beach, Florida, United States
Horizon Oncology Research, Inc
🇺🇸Lafayette, Indiana, United States
Southeast Georgia Health System
🇺🇸Brunswick, Georgia, United States
Weinberg Cancer Institute at Franklin Square
🇺🇸Baltimore, Maryland, United States
Dana-Farber Cancer Institute
🇺🇸Boston, Massachusetts, United States
Ashland-Bellefonte Cancer Center
🇺🇸Ashland, Kentucky, United States
Essentia Health Oncology Clinical Trials
🇺🇸Duluth, Minnesota, United States
Montana Cancer Institute Foundation
🇺🇸Missoula, Montana, United States
Metro MN CCOP/Park Nicollet Institute
🇺🇸Saint Louis Park, Minnesota, United States
QCCA - Pontchartrain Cancer Center
🇺🇸Covington, Louisiana, United States
Oncology Hematology Associates of Southwest Indiana
🇺🇸Newburgh, Indiana, United States
Detroit Clinical Research Center
🇺🇸Farmington Hills, Michigan, United States
Mercy Cancer Center - Joplin
🇺🇸Joplin, Missouri, United States
MCDA - Central Care Center
🇺🇸Bolivar, Missouri, United States
Missouri Baptist Medical Center
🇺🇸Saint Louis, Missouri, United States
Mary Bird Perkins Cancer Center (Baton Rouge)
🇺🇸Baton Rouge, Louisiana, United States
Saint Peter's University Hospital
🇺🇸New Brunswick, New Jersey, United States
Southeast Nebraska Cancer Center
🇺🇸Lincoln, Nebraska, United States
Northern Indiana Cancer Research Consortium
🇺🇸South Bend, Indiana, United States
Genesys Hurley Cancer Institute
🇺🇸Flint, Michigan, United States
Siouxland Hematology-Oncology Associates
🇺🇸Sioux City, Iowa, United States
Michigan State University/Breslin Cancer Center
🇺🇸Lansing, Michigan, United States
Renown Regional Medical Center
🇺🇸Reno, Nevada, United States
Heartland Regional Medical Center (Heartland Health)
🇺🇸Saint Joseph, Missouri, United States
Maryland Oncology Hematology
🇺🇸Columbia, Maryland, United States
Cancer Center of Kansas
🇺🇸Wichita, Kansas, United States
Southeast Cancer Center
🇺🇸Cape Girardeau, Missouri, United States
Englewood Hospital and Medical Center
🇺🇸Englewood, New Jersey, United States
Somerset Medical Center 110 Rehill Avenue
🇺🇸Somerville, New Jersey, United States
University Hospitals, Case Medical Center
🇺🇸Cleveland, Ohio, United States
Togus Va Medical Center
🇺🇸Augusta, Minnesota, United States
Cancer and Hematology Centers of Western Michigan
🇺🇸Grand Rapids, Michigan, United States
St. Vincent Frontier Cancer Center
🇺🇸Billings, Montana, United States
Maimonides Cancer Center
🇺🇸Brooklyn, New York, United States
Cotton O'Neil Clinical Research/ Stormont Vail Health
🇺🇸Topeka, Kansas, United States
St. John Providence Hospital System
🇺🇸Southfield, Michigan, United States
Hattiesburg Clinic Hematology/Oncology
🇺🇸Hattiesburg, Mississippi, United States
Western Maryland Health System
🇺🇸Cumberland, Maryland, United States
Huntington Medical Group
🇺🇸Huntington Station, New York, United States
UM St. Joseph's Medical Center
🇺🇸Towson, Maryland, United States
Ascension St. John Hospital_Hematology (was St. Johns Hospital and Hematology-Oncology Associates East PC )
🇺🇸Grosse Pointe Woods, Michigan, United States
Carroll Regional Cancer Center
🇺🇸Westminster, Maryland, United States
Boone Hospital Center
🇺🇸Columbia, Michigan, United States
Billings Clinic
🇺🇸Billings, Montana, United States
Southdale Cancer Clinic
🇺🇸Edina, Minnesota, United States
Oakwood Healthcare Inc.
🇺🇸Dearborn, Michigan, United States
Mary Bird Perkins Cancer Center at St. Tammany
🇺🇸Covington, Louisiana, United States
Columbia Comprehensive Cancer Care Clinic
🇺🇸Jefferson City, Missouri, United States
Cape Cod Hospital
🇺🇸Hyannis, Massachusetts, United States
Maine Research Associates/Central Maine Medicine
🇺🇸Lewiston, Maine, United States
Local Institution - 1110
🇺🇸Saint Louis, Missouri, United States
Mercy Cancer - St. Louis
🇺🇸Saint Louis, Missouri, United States
Mercy Research - Springfield
🇺🇸Springfield, Missouri, United States
Harry S Truman Memorial Veterans' Hospital
🇺🇸Columbia, Missouri, United States
West Michigan Cancer Center
🇺🇸Kalamazoo, Michigan, United States
Sparta Cancer Center
🇺🇸Sparta, New Jersey, United States
Regional One Health
🇺🇸Memphis, Tennessee, United States
Dallas VA Medical Center
🇺🇸Dallas, Texas, United States
Hematology-Oncology Associates of Northern New Jersey
🇺🇸Morristown, New Jersey, United States
John Theurer Cancer Center (Hackensack U Med Center)
🇺🇸Hackensack, New Jersey, United States
University of Tennessee Medical Center Cancer Intitute
🇺🇸Knoxville, Tennessee, United States
Local Institution - 1047
🇺🇸Johnson City, New York, United States
Texas Oncology - Sammons Cancer Center
🇺🇸Dallas, Texas, United States
St. Francis Hospital
🇺🇸Roslyn, New York, United States
Consultants in Medical Oncology and Hematology
🇺🇸Drexel Hill, Pennsylvania, United States
Good Samaritan Hospital Corvallis
🇺🇸Corvallis, Oregon, United States
Mid Ohio Oncology/Hematology, Inc., dba The Mark H. Zangmeister Center
🇺🇸Columbus, Ohio, United States
VA Medical Center Manchester
🇺🇸Manchester, New Hampshire, United States
Summa Health System
🇺🇸Akron, Ohio, United States
Leo W Jenkins Cancer Center
🇺🇸Greenville, North Carolina, United States
Ccs Oncology
🇺🇸Williamsville, New York, United States
Dayton Physicians
🇺🇸Kettering, Ohio, United States
New York Medical College
🇺🇸Valhalla, New York, United States
Kinston Medical Specialists
🇺🇸Kinston, North Carolina, United States
Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
University of Rochester ~ Wilmot Cancer Institute
🇺🇸Rochester, New York, United States
Hematology Oncology Associates of Central NY
🇺🇸East Syracuse, New York, United States
Oklahoma Cancer Specialist and Research Institute
🇺🇸Tulsa, Oklahoma, United States
Gabrail Cancer Center Research
🇺🇸Canton, Ohio, United States
Roger Williams Medical Center
🇺🇸Providence, Rhode Island, United States
University of Toledo Medical Center (Utmc)
🇺🇸Toledo, Ohio, United States
St Joseph Healthcare System
🇺🇸Paterson, New Jersey, United States
Bassett Heathcare Network
🇺🇸Cooperstown, New York, United States
C.R. Wood Cancer Center at Glens Falls Hospital
🇺🇸Glens Falls, New York, United States
Salem Health
🇺🇸Salem, Oregon, United States
Prairie Lakes Health Systen, Inc
🇺🇸Watertown, South Dakota, United States
Spartanburg Regional Medical Center
🇺🇸Spartanburg, South Carolina, United States
Rochester General Hospital
🇺🇸Rochester, New York, United States
Coastal Bend Cancer Center
🇺🇸Corpus Christi, Texas, United States
Christus Spohn Cancer Center
🇺🇸Corpus Christi, Texas, United States
HOLD - Texas Oncology, Dallas
🇺🇸Dallas, Texas, United States
Lancaster General Hospital
🇺🇸Lancaster, Pennsylvania, United States
Texas Oncology, Amarillo Cancer Center
🇺🇸Amarillo, Texas, United States
Gundersen Lutheran Inc
🇺🇸La Crosse, Wisconsin, United States
Peninsula Cancer Institute
🇺🇸Newport News, Virginia, United States
Kadlec Regional Medical Center (KRMC)
🇺🇸Kennewick, Washington, United States
Hematology and Oncology Assoc of NEPA
🇺🇸Dunmore, Pennsylvania, United States
Reading Hospital - McGlinn Cancer Institute
🇺🇸West Reading, Pennsylvania, United States
Allegheny Singer Research Institute (was West Penn Hospital)
🇺🇸Pittsburgh, Pennsylvania, United States
Lancaster Cancer Center
🇺🇸Lancaster, Pennsylvania, United States
BSL Health System (Harrington Cancer Center)
🇺🇸Amarillo, Texas, United States
Cancer Care Associates of York
🇺🇸York, Pennsylvania, United States
Hendrick Cancer Center
🇺🇸Abilene, Texas, United States
University of Pittsburgh Cancer Institute
🇺🇸Pittsburgh, Pennsylvania, United States
Benaroya Research Institute at Virginia Mason
🇺🇸Seattle, Washington, United States
Puerto Rico Hematology Oncology Group
🇵🇷Bayamon, Puerto Rico
Lynchburg Hematology Oncology Clinic
🇺🇸Lynchburg, Virginia, United States
West Virginia University
🇺🇸Morgantown, West Virginia, United States
Texas Oncology, Midland
🇺🇸Midland, Texas, United States
St. Vincent Hospital
🇺🇸Green Bay, Wisconsin, United States
Scott & White Healthcare
🇺🇸Round Rock, Texas, United States
VA Medical Center - White River Junction
🇺🇸White River Junction, Vermont, United States
Prisma Health Cancer Institute - Upstate
🇺🇸Greenville, South Carolina, United States
Texas Oncology, McAllen (plus 2 satelite sites)
🇺🇸McAllen, Texas, United States
Thompson Cancer Survival Center
🇺🇸Knoxville, Tennessee, United States
Wheaton Franciscan Cancer Care - All Saints
🇺🇸Racine, Wisconsin, United States
Texas Oncology - Fort Worth Cancer Center
🇺🇸Fort Worth, Texas, United States
Bellin Memorial Hospital/ Bellin Cancer Team
🇺🇸Green Bay, Wisconsin, United States
Memorial Hospital of Laramie County dba Cheyenne Regional Medical Center
🇺🇸Cheyenne, Wyoming, United States
PeaceHealth St Joseph Cancer Center
🇺🇸Bellingham, Washington, United States
Waukesha Memorial Hospital
🇺🇸Waukesha, Wisconsin, United States
Oncology and Hematology of South Texas, PA
🇺🇸Laredo, Texas, United States
Swedish Cancer Institute
🇺🇸Seattle, Washington, United States
Fundacion de lnvestigaci6n
🇵🇷San Juan, Puerto Rico
Baylor Research Institute dba Scott & White Memorial Hospital
🇺🇸Temple, Texas, United States
Blood and cancer Center of East Texas
🇺🇸Tyler, Texas, United States
Southwest Cancer Treatment & Research Center
🇺🇸Lubbock, Texas, United States
Providence Regional Cancer Partnership
🇺🇸Everett, Washington, United States
Community Cancer Trials of Utah
🇺🇸Ogden, Utah, United States
Vista Oncology Inc. PS
🇺🇸Olympia, Washington, United States
Providence St. Mary Regional Cancer Center
🇺🇸Walla Walla, Washington, United States
VA Caribbean Healthcare System CRADA
🇵🇷San Juan, Puerto Rico
Vanderbilt-Ingram Cancer Center
🇺🇸Nashville, Tennessee, United States
Arizona Oncology
🇺🇸Phoenix, Arizona, United States
John D. Dingell VA Medical Center /Cynthia Marbury
🇺🇸Detroit, Michigan, United States
Henry Ford Health System
🇺🇸Detroit, Michigan, United States
INTEGRIS Cancer Institute Southwest Medical Center
🇺🇸Oklahoma City, Oklahoma, United States
INTEGRIS Cancer Institute of Oklahoma Proton Campus
🇺🇸Oklahoma City, Oklahoma, United States
Saint Joseph Hospital, Cancer Centers of Colorado
🇺🇸Denver, Colorado, United States
Local Institution - 1131
🇺🇸Portland, Oregon, United States
Providence Cancer Center
🇺🇸Portland, Oregon, United States
Foley Cancer Center/RRMC
🇺🇸Rutland, Vermont, United States
Froedtert & Medical College of Wisconsin CLCC
🇺🇸Milwaukee, Wisconsin, United States
Columbia St. Mary'S
🇺🇸Milwaukee, Wisconsin, United States
University Cancer Institute
🇺🇸Boynton Beach, Florida, United States
Center for Cancer and Blood Disorders
🇺🇸Bethesda, Maryland, United States
IU health Bloomington Hospital
🇺🇸Bloomington, Indiana, United States
Mercy Cancer Center
🇺🇸Sacramento, California, United States
University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Ce
🇺🇸Ann Arbor, Michigan, United States
Wake Forest Baptist Health
🇺🇸Winston-Salem, North Carolina, United States
Memorial Healthcare System
🇺🇸Pembroke Pines, Florida, United States
UTMB Galveston
🇺🇸Galveston, Texas, United States
Weill Cornell Medical College
🇺🇸New York, New York, United States
University of Florida
🇺🇸Gainesville, Florida, United States
Adventist Health System/Sunbelt, Inc.
🇺🇸Orlando, Florida, United States
Baptist Health Systems, Inc., DBA Baptist
🇺🇸Louisville, Kentucky, United States
Kansas City Veterans Affairs Medical Center
🇺🇸Kansas City, Missouri, United States
Research Medical Center
🇺🇸Kansas City, Missouri, United States
Albert Einstein College of Medicine - Montefiore Medical Center
🇺🇸Bronx, New York, United States
New York Cancer and Blood Specialists
🇺🇸Bronx, New York, United States
Charleston Hematology Oncology Associates, PA
🇺🇸Charleston, South Carolina, United States
Baptist Health Lexington
🇺🇸Lexington, Kentucky, United States
DuPage Medical Group - Oncology (University of Rodchester)
🇺🇸Hinsdale, Illinois, United States
Central Care Cancer Center
🇺🇸Garden City, Kansas, United States
Oncology Specialists, SC
🇺🇸Niles, Illinois, United States